Glutathione and methylation of inorganic arsenic in hamsters

Miyuki Hirata, Akira Hisanaga, Akiyo Tanaka, Noburu Ishinishi

研究成果: ジャーナルへの寄稿記事

21 引用 (Scopus)

抄録

The effect of giutathione (GSH) concentrations in livers and kidneys of hamsters on the toxicity and methylation of arsenite in these animals was studied. No significant changes in hepatic and renal GSH concentrations were observed after a single arsenite administration (5 mg As kg−1, p.o.). When buthionine sulfoximine (BSO), an inhibitor of GSH synthesis, was given (4 mmol kg−1, i.p.) two hours before administration of arsenite, hepatic and renal GSH concentrations were more severely and persistently depressed than in the case of BSO administration not followed by arsenite. Hamsters treated with BSO plus arsenite suffered from severe nephrotoxicity (acute renal failure) characterized by increases in plasma creatinine and urea nitrogen and by proximal tubular necrosis. Concurrently, transient hepatotoxicity was observed in the BSO plus arsenite group. Neither arsenite alone nor BSO alone produced liver or kidney injury. The BSO plus arsenite‐treated animals excreted in the urine only 3.5% of the arsenic dose during the 72 h period after administration of arsenite, probably because of a decrease in urine volume caused by kidney injury, whereas the arsenite‐only group excreted 27%. In addition, BSO pretreatment influenced the relative proportion of arsenic metabolites excreted in the urine during the first 24 h after administration. Urinary metabolites in the BSO plus arsenite group were predominantly inorganic arsenic. These results suggest that GSH provides protection against arsenic toxicity.

元の言語英語
ページ(範囲)315-321
ページ数7
ジャーナルApplied Organometallic Chemistry
2
発行部数4
DOI
出版物ステータス出版済み - 1 1 1988

Fingerprint

Buthionine Sulfoximine
Methylation
Arsenic
Glutathione
Metabolites
Liver
Toxicity
Animals
arsenite
Urea
Creatinine
Nitrogen
Plasmas

All Science Journal Classification (ASJC) codes

  • Chemistry(all)
  • Inorganic Chemistry

これを引用

Glutathione and methylation of inorganic arsenic in hamsters. / Hirata, Miyuki; Hisanaga, Akira; Tanaka, Akiyo; Ishinishi, Noburu.

:: Applied Organometallic Chemistry, 巻 2, 番号 4, 01.01.1988, p. 315-321.

研究成果: ジャーナルへの寄稿記事

Hirata, Miyuki ; Hisanaga, Akira ; Tanaka, Akiyo ; Ishinishi, Noburu. / Glutathione and methylation of inorganic arsenic in hamsters. :: Applied Organometallic Chemistry. 1988 ; 巻 2, 番号 4. pp. 315-321.
@article{c3e9ed0a945d44338d239776823784f1,
title = "Glutathione and methylation of inorganic arsenic in hamsters",
abstract = "The effect of giutathione (GSH) concentrations in livers and kidneys of hamsters on the toxicity and methylation of arsenite in these animals was studied. No significant changes in hepatic and renal GSH concentrations were observed after a single arsenite administration (5 mg As kg−1, p.o.). When buthionine sulfoximine (BSO), an inhibitor of GSH synthesis, was given (4 mmol kg−1, i.p.) two hours before administration of arsenite, hepatic and renal GSH concentrations were more severely and persistently depressed than in the case of BSO administration not followed by arsenite. Hamsters treated with BSO plus arsenite suffered from severe nephrotoxicity (acute renal failure) characterized by increases in plasma creatinine and urea nitrogen and by proximal tubular necrosis. Concurrently, transient hepatotoxicity was observed in the BSO plus arsenite group. Neither arsenite alone nor BSO alone produced liver or kidney injury. The BSO plus arsenite‐treated animals excreted in the urine only 3.5{\%} of the arsenic dose during the 72 h period after administration of arsenite, probably because of a decrease in urine volume caused by kidney injury, whereas the arsenite‐only group excreted 27{\%}. In addition, BSO pretreatment influenced the relative proportion of arsenic metabolites excreted in the urine during the first 24 h after administration. Urinary metabolites in the BSO plus arsenite group were predominantly inorganic arsenic. These results suggest that GSH provides protection against arsenic toxicity.",
author = "Miyuki Hirata and Akira Hisanaga and Akiyo Tanaka and Noburu Ishinishi",
year = "1988",
month = "1",
day = "1",
doi = "10.1002/aoc.590020407",
language = "English",
volume = "2",
pages = "315--321",
journal = "Applied Organometallic Chemistry",
issn = "0268-2605",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Glutathione and methylation of inorganic arsenic in hamsters

AU - Hirata, Miyuki

AU - Hisanaga, Akira

AU - Tanaka, Akiyo

AU - Ishinishi, Noburu

PY - 1988/1/1

Y1 - 1988/1/1

N2 - The effect of giutathione (GSH) concentrations in livers and kidneys of hamsters on the toxicity and methylation of arsenite in these animals was studied. No significant changes in hepatic and renal GSH concentrations were observed after a single arsenite administration (5 mg As kg−1, p.o.). When buthionine sulfoximine (BSO), an inhibitor of GSH synthesis, was given (4 mmol kg−1, i.p.) two hours before administration of arsenite, hepatic and renal GSH concentrations were more severely and persistently depressed than in the case of BSO administration not followed by arsenite. Hamsters treated with BSO plus arsenite suffered from severe nephrotoxicity (acute renal failure) characterized by increases in plasma creatinine and urea nitrogen and by proximal tubular necrosis. Concurrently, transient hepatotoxicity was observed in the BSO plus arsenite group. Neither arsenite alone nor BSO alone produced liver or kidney injury. The BSO plus arsenite‐treated animals excreted in the urine only 3.5% of the arsenic dose during the 72 h period after administration of arsenite, probably because of a decrease in urine volume caused by kidney injury, whereas the arsenite‐only group excreted 27%. In addition, BSO pretreatment influenced the relative proportion of arsenic metabolites excreted in the urine during the first 24 h after administration. Urinary metabolites in the BSO plus arsenite group were predominantly inorganic arsenic. These results suggest that GSH provides protection against arsenic toxicity.

AB - The effect of giutathione (GSH) concentrations in livers and kidneys of hamsters on the toxicity and methylation of arsenite in these animals was studied. No significant changes in hepatic and renal GSH concentrations were observed after a single arsenite administration (5 mg As kg−1, p.o.). When buthionine sulfoximine (BSO), an inhibitor of GSH synthesis, was given (4 mmol kg−1, i.p.) two hours before administration of arsenite, hepatic and renal GSH concentrations were more severely and persistently depressed than in the case of BSO administration not followed by arsenite. Hamsters treated with BSO plus arsenite suffered from severe nephrotoxicity (acute renal failure) characterized by increases in plasma creatinine and urea nitrogen and by proximal tubular necrosis. Concurrently, transient hepatotoxicity was observed in the BSO plus arsenite group. Neither arsenite alone nor BSO alone produced liver or kidney injury. The BSO plus arsenite‐treated animals excreted in the urine only 3.5% of the arsenic dose during the 72 h period after administration of arsenite, probably because of a decrease in urine volume caused by kidney injury, whereas the arsenite‐only group excreted 27%. In addition, BSO pretreatment influenced the relative proportion of arsenic metabolites excreted in the urine during the first 24 h after administration. Urinary metabolites in the BSO plus arsenite group were predominantly inorganic arsenic. These results suggest that GSH provides protection against arsenic toxicity.

UR - http://www.scopus.com/inward/record.url?scp=84990495118&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84990495118&partnerID=8YFLogxK

U2 - 10.1002/aoc.590020407

DO - 10.1002/aoc.590020407

M3 - Article

AN - SCOPUS:84990495118

VL - 2

SP - 315

EP - 321

JO - Applied Organometallic Chemistry

JF - Applied Organometallic Chemistry

SN - 0268-2605

IS - 4

ER -